HFMA survey of healthcare finance professionals highlights continuing pandemic-related challenges and some reasons for optimism
Results of HFMA's Outlook Survey show that the healthcare industry is still coping with the challenges of COVID-19 but has started to adapt to a post-pandemic future.
Medicare indirect medical education payments to teaching hospitals should be overhauled, MedPAC says
Although the proposals represent a significant change, most hospitals wouldn’t be projected to experience a large impact on their payments.
PwC report anticipates a 6.5% increase in healthcare costs in 2022, roughly in line with recent years
As the healthcare industry emerges from the COVID-19 pandemic, annual costs are expected to increase by slightly more than they did in recent pre-pandemic years.
Healthcare News of Note: Sg2 report says lower-acuity care to continue its migration outside of hospital walls
Healthcare News of Note for healthcare finance professionals is a roundup of recent news articles: Hospitals to continue to see loss of lower-acuity care, nursing shortage spurs health systems to offer sign-on bonuses and some newly passed state laws could put public health at risk.
Study quantifies the cost to physician practices of participating in the Merit-based Incentive Payment System
MIPS participation led to high administrative costs and a significant time drain, according to new research.
The other supply chain issue revealed by the pandemic: Generic drugs
HFMA President and CEO Joe Fifer discusses the need for hospitals and health systems to diversify the generic drug supply chain.
May marked the first increase in hospital employment so far in 2021
The employment picture took a positive turn for hospitals in May after the sector experienced a net loss of jobs in each of the first four months of 2021.
Why success in cost reduction is a matter of trust
According to a survey, healthcare organizations that discuss cost reduction with clinicians more often are better prepared to achieve cost-reduction goals. Find out what approaches can restore trust for a better bottom line in this research report.
The understated value and potential of the clinical laboratory
Healthcare finance leaders need to rethink the value of the clinical laboratory in terms of revenue potential.
New research suggests there’s no need to worry that patient experience surveys lead to low-value healthcare
Findings from a new study may assuage concerns that low-value care is encouraged through the use of patient experience ratings in payment formulas.